US 6,586,440 B2Granted

Pharmaceutical compositions of 5-alkynyl uracil compounds

AssigneeSmithKline Beecham Corporation

InventorsThomas Spector, David J. T. Porter, Saad George Rahim

Life of this patent

Estimating the term…

Abstract

This invention relates to pharmaceutical compositions of 5-alkynyluracil compounds in the form of tablets or capsules.

Claims4

Dependent claims

A pharmaceutical composition comprising uracil substituted in the 5-position by C2-4 alkynyl together with at least one pharmaceutically acceptable carrier, wherein the composition is a tablet or a capsule.

Dependencies are inferred from the claim text.

Facts

Application: 09/841,554Filed 23 Apr 2001 · continuation
Priority: GB 901589619 Jul 1990
Published: US 2001/0025033 A127 Sep 2001
Granted: 1 Jul 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07D 239/54
Two oxygen atoms: as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
A61K 31/505
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrimidines; Hydrogenated…
A61K 31/513
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof

Family

PCT/GB91/01197Parent of this continuation · filed 18 Jul 1991
Application08/336,717Parent of this continuation · filed 9 Nov 1994
Application08/835,394Parent of this continuation · filed 3 Apr 1997
US 2001/0025033 A1Pre-grant publication · published 27 Sep 2001
US 6,221,852 B1Parent of this continuation
US 5,643,913 AParent of this continuation
Application07/965,261Parent of this continuation
US 6,586,440 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Facts

Application

09/841,554Filed 23 Apr 2001 · continuation

Priority

GB 901589619 Jul 1990

Published

US 2001/0025033 A127 Sep 2001

Granted

1 Jul 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07D 239/54
Two oxygen atoms: as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
A61K 31/505
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrimidines; Hydrogenated…
A61K 31/513
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof

Family

PCT/GB91/01197Parent of this continuation · filed 18 Jul 1991

Application08/336,717Parent of this continuation · filed 9 Nov 1994

Application08/835,394Parent of this continuation · filed 3 Apr 1997

US 2001/0025033 A1Pre-grant publication · published 27 Sep 2001

US 6,221,852 B1Parent of this continuation

US 5,643,913 AParent of this continuation

Application07/965,261Parent of this continuation

US 6,586,440 B2This patent

From the US filing history. Foreign family members aren’t listed.